Amarantus Options Blood-based Alzheimer's Biomarkers from Georgetown | GenomeWeb

NEW YORK (GenomeWeb) – Amarantus announced today it has signed an option agreement with Georgetown University that could eventually give the firm an exclusive license to blood-based biomarkers related to Alzheimer's disease.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: gene flow between ancient chimpanzees and bonobos, and more.

A startup wants to match customers to wine based on their DNA and one critic calls the idea 'silly,' Stat News reports.

Researchers trace the origins of brown rats using genetic analysis to China, the New York Times reports.

In Nature this week: genetic history of HIV in the US, and more.